MDGL EV/EBITDA
-13.86
-0.85-6.53%
Wed, 22 Jan 2025 23:29:30 GMT
Summary:
As of January 23, 2025, MDGL EV/EBITDA is -13.86, with a fall of -0.85 (-6.53%) during the most recent trading day. Over the past year, it has dropped by -0.64 (-4.84%). MDGL EV/EBITDA is now -581.25% below its all-time high of 2.88.MDGL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -6.5% |
| 1 m1 month | -5.5% |
| 3 m3 months | -61.4% |
| 6 m6 months | -18.1% |
| ytdytd | -4.2% |
| 1 y1 year | -4.8% |
| 5 y5 years | -6.5% |
MDGL EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -11.59 | -19.6% | -14.70 | +5.7% |
| 3 m | 3-month | -8.59 | -61.4% | -15.39 | +9.9% |
| 6 m | 6-month | -8.59 | -61.4% | -15.39 | +9.9% |
| 1 y | 1-year | -8.39 | -65.2% | -16.69 | +17.0% |
| 3 y | 3-year | -3.65 | -279.7% | -19.47 | +28.8% |
| 5 y | 5-year | -3.65 | -279.7% | -19.47 | +28.8% |
| alltime | all time | 2.88 | -581.3% | -144.55 | +90.4% |
Madrigal Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -13.86(+4.2%) |
| 2024 | -13.30(+3.8%) |
| 2023 | -12.81(-25.0%) |
| 2022 | -17.09(+192.1%) |
| 2021 | -5.85(-27.8%) |
| 2020 | -8.10(-43.5%) |
| 2019 | -14.33(-65.4%) |
| 2018 | -41.38(+14.4%) |
| 2017 | -36.18(+473.4%) |
| Date | Value |
|---|---|
| 2016 | -6.31(+169.7%) |
| 2015 | -2.34(-24.3%) |
| 2014 | -3.09(-36.2%) |
| 2013 | -4.84(-47.3%) |
| 2012 | -9.18(+85.1%) |
| 2011 | -4.96(-27.2%) |
| 2010 | -6.81(-536.5%) |
| 2009 | 1.56(-188.6%) |
| 2008 | -1.76(-5.4%) |
| 2007 | -1.86 |
FAQ
- What is Madrigal Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Madrigal Pharmaceuticals?
- What is MDGL EV/EBITDA year-to-date change?
- What is Madrigal Pharmaceuticals EV/EBITDA year-on-year change?
What is Madrigal Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of MDGL is -13.86
What is the all time high EV/EBITDA for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high EV/EBITDA is 2.88
What is MDGL EV/EBITDA year-to-date change?
Madrigal Pharmaceuticals EV/EBITDA has changed by -0.56 (-4.21%) since the beginning of the year
What is Madrigal Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, MDGL EV/EBITDA has changed by -0.64 (-4.84%)